SEARCH

SEARCH BY CITATION

References

  • Hermann, A., Rauch, B.H., Braun, M., Schrör, K. & Weber, A.-A. (2001) Platelet CD40 ligand (CD40L): subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets, 12, 7482.DOI: 10.1080/09537100020031207
  • Hohlfeld, T., Zimmermann, N., Gams, E. & Schrör, K. (2000) Aspirin resistance coincides with platelet COX-2 expression but not with enhanced aspirin esterase activity. Circulation, 102 (suppl.), II237 (Abstract).
  • Matijevic-Aleksic, N., Sanduja, S.K., Wang, L.-H. & Wu, K.K. (1995) Differential expression of thromboxane A synthase and prostaglandin H synthase in megakaryocytic cell line. Biochimica et Biophysica Acta, 1269, 167175.
  • Patrignani, P., Sciulli, M.G., Manarini, S., Santini, G., Cerletti, C. & Evangelista, V. (1999) COX-2 is not involved in thromboxane biosynthesis by activated human platelets. Journal of Physiology and Pharmacology, 50, 661667.
  • Patrono, C. (1994) Aspirin as an antiplatelet drug. New England Journal of Medicine, 330, 12871294.
  • Patrono, C., Coller, B., Dalen, J.E., FitzGerald, G.A., Fuster, V., Gent, M., Hirsh, J. & Roth, G. (2001) Platelet-active drugs. The relationships among dose, effectiveness, and side effects. Chest, 119, 39S63S.
  • Schwarz, U.R., Geiger, J., Walter, U. & Eigenthaler, M. (1999) Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets. Thrombosis and Haemostasis, 82, 11451152.
  • Vane, J.R., Bakhle, Y.S. & Botting, R.M. (1998) Cyclooxygenases 1 and 2. Annual Reviews in Pharmacology and Toxicology, 38, 97120.
  • Weber, A.-A. & Schrör, K. (2001) Differential inhibition of adenosine diphosphate- versus thrombin receptor-activating peptide-stimulated platelet fibrinogen binding by abciximab due to different GPIIb/IIIa activation kinetics. Blood, 98, 16191621.
  • Weber, A.-A., Zimmermann, K.C., Meyer-Kirchrath, J. & Schrör, K. (1999) Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance. Lancet, 353, 900.
  • Weber, A.-A., Liesener, S., Schanz, A., Hohlfeld, T. & Schrör, K. (2000) Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects. Platelets, 11, 177182.
  • Zimmermann, N., Kiensle, P., Weber, A.-A., Winter, J., Gams, E., Schrör, K. & Hohlfeld, T. (2001) Aspirin resistance after coronary artery bypass grafting. Journal of Thoracic and Cardiovascular Surgery, 121, 982984.